Comparative Study of Subcutaneous Versus Intravenous IgG Replacement Therapy in Pediatric Patients with Primary Immunodeficiency Diseases: A Multicenter Study in Argentina

被引：0
|
作者：
Liliana Bezrodnik
Andrea Gómez Raccio
Gabriela Belardinelli
Lorena Regairaz
Damacia Díaz Ballve
Gisela Seminario
Ileana Moreira
Carlos Riganti
Claudio Cantisano
Héctor Díaz
Daniela Di Giovanni
机构：
[1] Inmunología,
[2] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
[3] Inmunología,undefined
[4] Hospital de Niños “Sor María Ludovica”,undefined
[5] Inmunología,undefined
[6] Hospital de Niños Pedro Elizalde,undefined
[7] Inmunología,undefined
[8] Hospital de Niños “Dr. Ricardo Gutiérrez”,undefined
来源：
Journal of Clinical Immunology | 2013年 / 33卷
关键词：
Argentina; children; immunoglobulin therapy; intravenous; primary immunodeficiency; subcutaneous; Beriglobina P;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1216 / 1222
页数：6
相关论文
共 50 条
  • [41] Prospective Study on CVID Patients with Adverse Reactions to Intravenous or Subcutaneous IgG Administration
    Isabella Quinti
    Annarosa Soresina
    Carlo Agostini
    Giuseppe Spadaro
    Andrea Matucci
    Ifigeneia Sfika
    Helene Martini
    Federica Borghese
    Andrea Guerra
    Vultaggio Alessandra
    Marcella Visentini
    Alessandro Plebani
    Massimo Fiorilli
    Journal of Clinical Immunology, 2008, 28 : 263 - 267
  • [42] Evaluating Dose Ratio of Subcutaneous to Intravenous Immunoglobulin Therapy Among Patients With Primary Immunodeficiency Disease Switching to 20% Subcutaneous Immunoglobulin Therapy
    Krishnarajah, Girishanthy
    Lehmann, Jee-Yeon K.
    Ellman, Brian
    Bhak, Rachel H.
    DerSarkissian, Maral
    Leader, Deane, Jr.
    Bullinger, Ann L.
    Duh, Mei Sheng
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (15): : S475 - S481
  • [43] TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB VERSUS VEDOLIZUMAB TREATMENT: A PROSPECTIVE MULTICENTER STUDY
    Brescia, I., V
    Principi, M. B.
    Ditonno, I
    Stasi, E.
    Mazzuoli, S.
    Lacavalla, I
    Di Leo, A.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S242 - S242
  • [44] The evaluation of malignancies in Turkish primary immunodeficiency patients; a multicenter study
    Cekic, Sukru
    Metin, Ayse
    Aytekin, Caner
    Karaca, Neslihan Edeer
    Baris, Safa
    Karali, Yasin
    Kiykim, Ayca
    Aydiner, Elif Karakoc
    Ozen, Ahmet
    Aslan, Torehan
    Sevinir, Betul
    Aksu, Guzide
    Kutukculer, Necil
    Kilic, Sara Sebnem
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2020, 31 (05) : 528 - 536
  • [45] EFFECTIVENESS AND SAFETY OF INTRAVENOUS VERSUS SUBCUTANEOUS TOCILIZUMAB IN TAKAYASU ARTERITIS: MULTICENTER RETROSPECTIVE STUDY
    Mekinian, A.
    Saadoun, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 639 - 639
  • [46] Primary immunodeficiency disease: a cost-utility analysis comparing intravenous vs subcutaneous immunoglobulin replacement therapy in Australia
    Windegger, Tanja M.
    Nghiem, Son
    Nguyen, Kim-Huong
    Fung, Yoke L.
    Scuffham, Paul A.
    BLOOD TRANSFUSION, 2020, 18 (02) : 96 - 105
  • [47] Use of Home-Based Subcutaneous Immunoglobulin Therapy in Elderly Patients With Primary Immunodeficiency Diseases
    Guthrie, Robert M.
    POSTGRADUATE MEDICINE, 2013, 125 (01) : 169 - 171
  • [48] Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases
    Patel, Niraj C.
    Walter, Jolan E.
    Wasserman, Richard L.
    Rubinstein, Arye
    Kankirawatana, Suthida
    Shepherd, Meagan W.
    Greco, Erin
    Li, Zhaoyang
    Russo-Schwarzbaum, Sharon
    Saeed-Khawaja, Shumyla
    Mccoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2025, 45 (01)
  • [49] Trough Concentrations of Specific Antibodies in Primary Immunodeficiency Patients Receiving Intravenous Immunoglobulin Replacement Therapy
    Hassin, Ori
    Abu Freih, Yahya
    Hazan, Ran
    Lev, Atar
    Zrihen, Keren S.
    Somech, Raz
    Broides, Arnon
    Nahum, Amit
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (04) : 1 - 9
  • [50] Safety, Efficacy, and Pharmacokinetics of Flebogamma® 5% [Immune Globulin Intravenous (Human)] for Replacement Therapy in Primary Immunodeficiency Diseases
    Melvin Berger
    Paul J. Pinciaro
    Journal of Clinical Immunology, 2004, 24 : 389 - 396
12345